Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
MSMR
|
July 4, 2013
Outbreak of Group A beta hemolytic Streptococcus pharyngitis in a Peruvian military facility, April 2012
Mariana Ramos, Ruben Valle, Eric J Reaves, et al.
Translational Andrology and Urology
|
May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma
Albert Jang, Sulin Wu, Hamsa L S Kumar, et al.
Cancers
|
February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer
Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Regulatory Toxicology and Pharmacology : RTP
|
July 6, 2021
Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies
Shumin Zhang, Chantal E Holy, Gary Eichenbaum, et al.
NEJM Evidence
|
October 28, 2025
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
Alicia K Morgans, Soumyajit Roy, Angela Y Jia, et al.
The Oncologist
|
August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?
Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Clinical Genitourinary Cancer
|
November 12, 2024
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
Petros Grivas, Pedro Barata, Helen Moon, et al.
The Journal of Urology
|
July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
Soumyajit Roy, Yilun Sun, Kim N Chi, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
September 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank
Laura Bukavina, Ilaha Isali, Sneha Parekh, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation
Laura Bukavina, Rashida Ginwala, Mohit Sindhani, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
MSMR
|
July 4, 2013
Outbreak of Group A beta hemolytic Streptococcus pharyngitis in a Peruvian military facility, April 2012
Mariana Ramos, Ruben Valle, Eric J Reaves, et al.
Translational Andrology and Urology
|
May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma
Albert Jang, Sulin Wu, Hamsa L S Kumar, et al.
Cancers
|
February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer
Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Regulatory Toxicology and Pharmacology : RTP
|
July 6, 2021
Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies
Shumin Zhang, Chantal E Holy, Gary Eichenbaum, et al.
NEJM Evidence
|
October 28, 2025
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
Alicia K Morgans, Soumyajit Roy, Angela Y Jia, et al.
The Oncologist
|
August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?
Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Clinical Genitourinary Cancer
|
November 12, 2024
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
Petros Grivas, Pedro Barata, Helen Moon, et al.
The Journal of Urology
|
July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
Soumyajit Roy, Yilun Sun, Kim N Chi, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
September 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank
Laura Bukavina, Ilaha Isali, Sneha Parekh, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation
Laura Bukavina, Rashida Ginwala, Mohit Sindhani, et al.
Page
of 8